Intein-modified proteases, their production and industrial applications
Methods for producing intein-modified proteases are provided. Expression cassettes and vectors for using to genetically engineer hosts are described. Hosts genetically engineered to express one or more intein-modified proteases using expression cassettes and vectors of the invention are also provided. Methods to produce a protease and regulate its activity are described.
1. An animal feed comprising a first portion and a second portion of an intein-modified protease,
wherein the first portion of the intein-modified protease comprises an N-extein of a target protease and an N-intein of an intein, and a carboxy terminus of the N-extein is fused to an amino terminus of the N-intein, the second portion of the intein-modified protease comprises a C-intein of the intein and a C-extein of the target protease, and a carboxy terminus of the C-intein is fused to an amino terminus of the C-extein, wherein the N-intein includes a sequence with at least 90% identity to the reference sequence of SEQ ID NO: 537, and the C-intein includes a sequence with at least 90% identity to the reference sequence of SEQ ID NO: 538, and
wherein the target protease comprises a sequence with at least 90% identity to the reference sequence of SEQ ID NO: 57, and has a serine at a position aligned to position 109, 267, or 291 of SEQ ID NO: 57, or a threonine at a position aligned to position 292 of SEQ ID NO: 57, and the C-intein is fused to an amino acid residue aligned to position 109, 243, 267, 291 or 292 of SEQ ID NO: 57 of the target protease, each of the first portion and the second portion is in a dry form, the first portion is separated from the second portion, and the intein is capable of effecting trans-splicing of the intein modified protease upon mixing of the first portion and the second portion to form a mixture and hydration of the mixture.
2. The animal feed of claim 1 , wherein each of the N-intein and the C-intein is fused in such a position as to substantially reduce or inhibit the activity of the target protease.
3. The animal feed of claim 1 , wherein the first portion includes a sequence with at least 90% identity to a reference sequence selected from the group consisting of: SEQ ID NO: 454, SEQ ID NO: 461, SEQ ID NO: 462, SEQ ID NO: 463, SEQ ID NO: 464, and SEQ ID NO: 465.
4. The animal feed of claim 3 , wherein the second portion includes a sequence with at least 90% identity to a reference sequence selected from the group consisting of: SEQ ID NO: 455, SEQ ID NO: 481, SEQ ID NO: 482, SEQ ID NO: 483, SEQ ID NO: 484, and SEQ ID NO: 485.
5. An expression cassette comprising:
a polynucleotide encoding at least one of i) a first portion of an intein-modified protease that includes a N-extein of a target protease and an N-intein of an intein, and a carboxy terminus of the N-extein is fused to an amino terminus of the N-intein, and ii) a second portion of an intein-modified protease having a C-intein of the intein and a C-extein of the target protease, and a carboxy terminus of the C-intein is fused to an amino terminus of the C-extein,
wherein a nucleotide sequence having at least 90% identity to the reference sequence of SEQ ID NO: 674 encodes the N-intein, and a nucleotide sequence having at least 90% identity to the reference sequence of SEQ ID NO: 675 encodes the C-intein,
wherein the N-extein comprises a sequence with at least 90% identity to a first sequence that is one of positions 1-108, 1-242, 1-266, 1-290 or 1-291 of the reference sequence of SEQ ID NO: 57, and
wherein the C-extein comprises a sequence with at least 90% identity to a second sequence that is one of positions 109-354, 243-354, 267-354, 291-354 or 292-354 of the reference sequence of SEQ ID NO: 57, and has a serine at a position aligned to position 109, 243, 267, or 291 of SEQ ID NO: 57 or a threonine at a position aligned to position 292 of SEQ ID NO: 57, and the C-intein is fused to an amino acid residue aligned to position 109, 243, 267, 291 or 292 of SEQ ID NO: 57.
6. The expression cassette of claim 5 , wherein the N-intein or the C-intein is fused in such a position as to substantially reduce or inhibit the activity of the target protease.
7. The expression cassette of claim 5 , wherein the sequence encoding the first portion has at least 90% identity to a reference sequence selected from the group consisting of: SEQ ID NOS: 587 and 594-598, and the sequence encoding the second portion has at least 90% identity to a reference sequence selected from the group consisting of: SEQ ID NOS: 588, and 614-618.
8. A host comprising the expression cassette of claim 5 .
9. The host of claim 8 , wherein the host is Escherichia coli.
10. A method of preparing an animal feed comprising causing splicing of an intein-modified protease included in the animal feed of claim 1 .
11. The method of claim 10 , wherein the splicing occurs upon feeding the animal feed to an animal.
12. The method of claim 10 , wherein prior to the step of causing splicing the method further comprises adding to the animal feed at least one exogenous enzyme selected from the group consisting of a xylanase, a β-glucanase, a protease, an amylase, a phytase, and an endo-mannanase.
13. The method of claim 10 , wherein prior to the step of causing splicing the method further comprises adding to the animal feed at least one more protease or a feed supplement.